MTRI dilution watch: offerings and filings

MTRI (InMed Pharmaceuticals Inc.) filed a new prospectus supplement (424B) on Wednesday, October 28, 2026 (S-1). Below is every offering event for the name in the last 60 days, newest first, and its Momo Meter alert history: 1 alert in 90 days, last Nov 12, 3:08 PM.

DateEventMomo Meter alerts, 90 days
Oct 28, 2026New 424B filed a new prospectus supplement (424B), S-1, shelf1 last Nov 12, 3:08 PM
Oct 1, 2026Effective registration went effective, S-1, shelf1 last Nov 12, 3:08 PM
Oct 1, 2026Priced priced an offering, S-1, shelf1 last Nov 12, 3:08 PM

A registration (S-1 or S-3) is permission to sell new shares later; effective means the SEC cleared it; a pricing or a 424B supplement means shares are being sold now; an MEF adds shares to a sale in progress. New shares sold into the market dilute existing holders.

All recent offering events